|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
94,670,000 |
Market
Cap: |
98.46(M) |
Last
Volume: |
940,193 |
Avg
Vol: |
715,711 |
52
Week Range: |
$0.754 - $7.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schoeneck James A |
President and CEO |
|
2014-12-02 |
4 |
AS |
$15.85 |
$582,233 |
D/D |
(36,727) |
52,930 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-12-02 |
4 |
AS |
$15.85 |
$139,808 |
D/D |
(8,819) |
32,501 |
|
- |
|
Vargas Thadd M |
Senior VP, BD |
|
2014-12-02 |
4 |
AS |
$15.85 |
$130,740 |
D/D |
(8,247) |
69,443 |
|
- |
|
Moretti August J |
Chief Financial Officer |
|
2014-12-02 |
4 |
AS |
$15.85 |
$84,639 |
D/D |
(5,339) |
22,564 |
|
- |
|
Staple Peter D |
Director |
|
2014-11-25 |
4 |
OE |
$5.04 |
$50,400 |
D/D |
10,000 |
50,000 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-11-19 |
4 |
AS |
$15.36 |
$1,090,347 |
D/D |
(71,000) |
17,211 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-11-19 |
4 |
OE |
$6.17 |
$438,070 |
D/D |
71,000 |
88,211 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-08-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
143,408 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-08-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
12,898 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-08-01 |
4 |
OE |
$6.11 |
$183,300 |
D/D |
30,000 |
42,898 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-05-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
88,408 |
113,408 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-05-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
88,408 |
12,898 |
|
- |
|
Vargas Thadd M |
Senior VP, BD |
|
2014-05-16 |
4 |
OE |
$3.09 |
$120,634 |
D/D |
39,040 |
53,119 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-05-09 |
4 |
OE |
$6.17 |
$24,680 |
D/D |
4,000 |
15,396 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-05-09 |
4 |
OE |
$3.45 |
$135,750 |
D/D |
30,000 |
126,306 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-03-14 |
4 |
S |
$14.74 |
$322,328 |
D/D |
(21,875) |
11,396 |
|
- |
|
Gosling Matthew M |
Senior VP, General Counsel |
|
2014-03-14 |
4 |
OE |
$3.09 |
$67,594 |
D/D |
21,875 |
33,271 |
|
- |
|
Vargas Thadd M |
Senior VP, BD |
|
2014-03-14 |
4 |
S |
$14.69 |
$938,210 |
D/D |
(63,869) |
14,079 |
|
- |
|
Vargas Thadd M |
Senior VP, BD |
|
2014-03-14 |
4 |
OE |
$5.08 |
$50,800 |
D/D |
10,000 |
77,948 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-03-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
96,306 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-03-14 |
4 |
S |
$14.54 |
$247,124 |
I/I |
(17,000) |
99,306 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-01-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
40,700 |
221,306 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2014-01-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,700 |
15,732 |
|
- |
|
Schoeneck James A |
President and CEO |
|
2013-12-02 |
4 |
AS |
$8.40 |
$144,454 |
D/D |
(17,192) |
116,306 |
|
- |
|
Vargas Thadd M |
Senior VP, BD |
|
2013-12-02 |
4 |
AS |
$8.40 |
$44,508 |
D/D |
(5,296) |
61,698 |
|
- |
|
246 Records found
|
|
Page 7 of 10 |
|
|